|
Market Cap (4-Jun) $61,568,592 (1,444th) |
Close (30-Jun) $0.076 |
Volume (30-Jun) 120,981 |
Shortsold (26-May) 11,577 (0.00%) (629th) |
|
52w High $0.425 |
52w Low $0.056 |
P/E - |
EPS -0.02 |
ATX released this announcement to the ASX on 22 July 2022, 9:54. The announcement is not marked as price sensitive, and is 28 page(s) in length and 591.2kb in size.
You can view all announcements from ATX and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATX was 0.155% short sold according to ASIC data. It was ranked the 452nd most shorted stock on the ASX. It remains ranked 629th as of the latest reported data (26 May 2026).
| Other Recent Announcements from ATX | |
|---|---|
| AMP945 International Nonproprietary Name Narmafotinib | 21 June 2023, 8:34 |
| Amplia AGM to be held Thursday 24 August 2023 | 19 June 2023, 17:34 |
| Key to Corporate Governance Disclosures | 31 May 2023, 8:14 |
| Notice of Annual General Meeting/Proxy - YE 31 March 2022 | 22 July 2022, 9:54 |
| Change of Director's Interest Notice - Dr. Chistopher Burns | 7 July 2022, 16:49 |
| Change of Director's Interest Notice - Dr. Robert Peach | 7 July 2022, 16:47 |
| Change of Director's Interest Notice - Dr. John Lambert | 7 July 2022, 16:46 |
You must be logged in to post a reply.
Amplia Therapeutics 